Skip to main content

Last Updated on February 16, 2024

Personal data is sensitive.

Pharmaceutical companies marketing their products in Europe are subject to the General Data Protection Regulation (GDPR), which governs the collection, storage and use of personal data within the European Union (EU). Here are some key things that pharmaceutical companies should know about GDPR (https://gdpr.eu/).

It is all about sensitive personal data.

GDPR applies to any information that can be used to identify an individual, including names, addresses and online identifiers. Pharmaceutical companies often process sensitive personal data, such as e-consent, medical information and health records, which are subject to special protection under GDPR.

It requires robust data protection measures.

GDPR requires organizations to implement appropriate technical and organizational measures to ensure the security of personal data. Pharmaceutical companies must ensure that they have robust systems in place to protect the sensitive personal data they process, including measures to prevent unauthorized access and loss of data.

 

Data minimization.

GDPR requires organisations to only collect e-permissions regarding the personal data that is necessary for a specific purpose. Pharmaceutical companies must ensure that they only collect and process the personal data that is necessary for their activities.

GDPR gives individuals control over their personal data.

Individuals have the right to access their personal data and to have it deleted if they so choose. Pharmaceutical companies must provide individuals with this information in a clear and concise manner and must delete the data when requested.

It requires data protection impact assessments.

GDPR requires organizations to carry out data protection impact assessments (DPIAs) in certain circumstances. Pharmaceutical companies must carry out a DPIA when they are processing personal data that is likely to result in a high risk to individuals’ rights and freedoms.

Conclusion.

In conclusion, pharmaceutical companies must ensure that they are fully compliant with GDPR when processing personal data. They must implement appropriate technical and organizational measures to protect the sensitive personal data they process and must carry out data protection impact assessments when necessary. By doing so, they can ensure that they are operating in a manner that is consistent with the principles of GDPR and that protects the rights and freedoms of individuals.

What can OptInsight do for you?

We offer solutions and services for pharma & life sciences companies with focus on increasing your reach to healthcare professionals (HCPs).

The OptInsight e-consent and preference management solution allows pharmaceutical companies to manage the collection, storage and use of personal data in a compliant and secure manner. It provides a centralized platform for managing e-consent records (opt-ins AND opt-outs) and preferences, including the mandatory audit trail. It functions as a single source of truth, preventing scattered personal and consent data throughout your company. It also shows the latest consent status and preferences, which allows you to engage with HCPs based on the right data.

With our partner ecosystem, we can also support you on collecting opt-ins (up to 50%) and preferences (increase of up to 50% of HCP preferences), adding touch points to your customer journey with high end phone calls, improving the quality of data collected, creating social media campaigns, construction of websites and building HCP portals. Are you interested? Have a look at www.opt-insight.com or contact me at erik.luttik@opt-insight.com.

Curious?
Schedule a meeting with us.

Tip: involve your colleagues from other departments within your company.
In this way we can instantly answer questions and provide clarity from various points of view.

Erik

Marketing & Product Director

Leave a Reply